Health

STAT+: Flagship opens biotech-creation outpost in the U.K.

Want to stay on top of the science and politics driving biotech today?

✦ Extractive summary — built from the sources' own reporting•From 1 source•1 min read•Updated November 17, 2026, 5:05 PM UTC
Key points
  • Continue to STAT+ to read the full story….
  • The need-to-know this morning Isomorphic Labs, the AI drug developer, raised $5 billion in private financing.
  • We’ve got a lot of news to get into today, including some big developments in oncology.

Sellas’ blood cancer immunotherapy cut risk of death An experimental drug from Sellas Life Sciences reduced the risk of death by 41% compared to standard treatment for patients with an advanced stage of acute myeloid leukemia, the company said this morning.

Sign up to get our biotech newsletter in your inbox.

How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →

Advertisement

Every article behind this summary — 1 article from 1 outlet